Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Int J Cancer. 2019 Jul 31;146(9):2433–2441. doi: 10.1002/ijc.32569

Table 1.

Population demographic and tumor characteristics for children with germ cell tumors by race/ethnicity and sex, SEER 18 2000-2015

Males Females
Non-
Hispanic
White
Black Asian/
Pacific Islander
Hispanic Non-
Hispanic
White
Black Asian/
Pacific Islander
Hispanic
N (%)
1241 (51.0)
N (%)
77 (3.2)
N (%)
208 (8.6)
N (%)
906 (37.3)
N (%)
395 (44.8)
N (%)
137 (15.5)
N (%)
97 (11.0)
N (%)
253 (28.7)
n (%) n (%) n (%) n (%) chi-squared
p-value
n (%) n (%) n (%) n (%) chi-squared
p-value
Age at diagnosis (years)
 Average (Standard Deviation) 15.8 (4.5) 14.6 (5.5) 13.9 (5.7) 15.4 (4.8) 11.8 (6.0) 12.0 (6.1) 12.1 (5.6) 12.9 (5.0)
 <1 22 (1.8) 3 (3.9) 8 (3.8) 21 (2.3) 0.003 18 (4.6) 11 (8.0) 5 (5.2) 6 (2.4) 0.08
 1-4 54 (4.4) 6 (7.8) 19 (9.1) 48 (5.3) 50 (12.7) 12 (8.8) 9 (9.3) 16 (6.3)
 5-9 33 (2.7) 1 (1.3) 8 (3.8) 27 (3.0) 53 (13.4) 12 (8.8) 10 (10.3) 30 (11.9)
 10-14 138 (11.1) 12 (15.6) 38 (18.3) 100 (11.0) 106 (26.8) 37 (27.0) 34 (35.1) 81 (32.0)
 15-19 994 (80.1) 55 (71.4) 135 (64.9) 710 (78.4) 168 (42.5) 65 (47.4) 39 (40.2) 120 (47.4)
Tumor Location
 Intracranial/Intraspinal 237 (19.1) 31 (40.3) 89 (42.8) 137 (15.1) <0.0001 61 (15.4) 18 (13.1) 34 (35.1) 34 (13.4) <0.0001
 Extracranial/Extragonadal 58 (4.7) 8 (10.4) 31 (14.9) 66 (7.3) 83 (21.0) 46 (33.6) 17 (17.5) 44 (17.4)
 Gonadal 946 (76.2) 38 (49.4) 88 (42.3) 703 (77.6) 251 (63.5) 73 (53.3) 46 (47.4) 175 (69.2)
Tumor Histology
 Germinoma 361 (29.1) 37 (48.1) 105 (50.5) 248 (27.4) <0.0001 187 (47.3) 38 (27.7) 51 (52.6) 117 (46.2) 0.0002
 Yolk sac tumor 80 (6.4) 11 (14.3) 37 (17.8) 89 (9.8) 92 (23.3) 41 (29.9) 26 (26.8) 48 (19.0)
 Mixed 613 (49.4) 20 (26.0) 51 (24.5) 447 (49.3) 91 (23.0) 36 (26.3) 13 (13.4) 64 (25.3)
 Other 187 (15.1) 9 (11.7) 15 (7.2) 122 (13.5) 25 (6.3) 22 (16.1) 7 (7.2) 24 (9.5)
Tumor size (cm)
 ≤2 202 (23.6) 10 (21.7) 22 (15.9) 103 (15.4) <0.0001 21 (8.8) 7 (8.5) 4 (6.6) 10 (6.4) 0.06
 >2-≤5 434 (50.7) 29 (63.0) 76 (55.1) 303 (45.2) 40 (16.7) 8 (9.8) 19 (31.1) 27 (17.2)
 >5 220 (25.7) 7 (15.2) 40 (29.0) 265 (39.5) 179 (74.6) 67 (81.7) 38 (62.3) 120 (76.4)
 missing 385 31 70 235 155 55 36 96
Stage of disease
 Local 784 (64.6) 43 (58.9) 129 (64.2) 497 (56.3) 0.002 167 (44.9) 52 (40.3) 55 (57.3) 105 (43.0) 0.02
 Regional 245 (20.2) 16 (21.9) 43 (21.4) 194 (22.0) 127 (34.1) 36 (27.9) 20 (20.8) 70 (28.7)
 Distant 185 (15.2) 14 (19.2) 29 (14.4) 192 (21.7) 78 (21.0) 41 (31.8) 21 (21.9) 69 (28.3)
 missing 27 4 7 23 23 8 1 9
Surgery (yes) 1073 (86.5) 62 (80.5) 139 (66.8) 792 (87.4) 334 (84.6) 115 (83.9) 71 (73.2) 214 (84.6)
Radiation (yes) 246 (19.8) 32 (41.6) 78 (37.5) 144 (15.9) 51 (12.9) 14 (10.2) 27 (27.8) 30 (11.9)
Chemotherapy (yes) 667 (53.7) 44 (57.1) 133 (63.9) 526 (58.1) 277 (70.1) 96 (70.1) 74 (76.3) 182 (71.9)
Vital status
 Alive 1172 (94.4) 70 (90.9) 181 (87.0) 810 (89.4) <0.0001 369 (93.4) 128 (93.4) 89 (91.8) 241 (95.3) 0.6
 Dead 69 (5.6) 7 (9.1) 27 (13.0) 96 (10.6) 26 (6.6) 9 (6.6) 8 (8.2) 12 (4.7)
Year diagnosed
 2000:2004 394 (31.7) 30 (39.0) 59 (28.4) 200 (22.1) <0.0001 136 (34.4) 41 (29.9) 26 (26.8) 75 (29.6) 0.5
 2005:2009 419 (33.8) 23 (29.9) 58 (27.9) 283 (31.2) 116 (29.4) 40 (29.2) 34 (35.1) 71 (28.1)
 2010:2015 428 (34.5) 24 (31.2) 91 (43.8) 423 (46.7) 143 (36.2) 56 (40.9) 37 (38.1) 107 (42.3)